The table below shows Entera Bio Ltd.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$3.09M
-$1.40M
-$1.86M
-$1.61M
-$4.79M
-$2.32M
Capital expenditure
$0.00
$8.00K
$0.00
$11.00K
$23.00K
$0.00
Investing cash flow
$0.00
-$8.00K
$0.00
-$11.00K
-$23.00K
$0.00
Dividends paid
-
-
-
-
ENTX operating cash flow (10-K history)
Entera Bio Ltd. reported operating cash flow of -$7.37M for fiscal year 2025. That is down 8.1% from -$6.82M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$10.56M (FY 2020) to -$7.37M. Figures come from the company's audited annual reports as filed with the SEC.